MIAMI LAKES, Fla., May 15, 2012 /PRNewswire/ -- Fuse Science Inc. (OTCQB: DROP), (www.fusescience.com) announced today that it has added another 200 independent pharmacies in South Florida through a distribution partnership with GAT Trading Inc. out of Doral, Florida. Distribution build out has begun, led by GAT Trading President, Gustavo Tobon, in response to interest by pharmacists within his network regarding the efficacy of the EnerJel product. Fuse Science previously announced its global distribution partnership with GNC as its market lead-in position and expects to announce additional distribution partnerships in the coming days and weeks.
“The initial response to the EnerJel product has been very positive by the pharmacists and their staff,” said Gustavo Tobon. “EnerJel represents a highly effective all natural alternative to address muscle fatigue and joint discomfort which is one of the largest issues for their client base. I am very optimistic that this product will become a market leader based on consumer response.”
“We continue to be excited about the technology that resides within Fuse Science and the fact that our products, beginning with EnerJel, are having a big impact on solving consumers unmet needs,” said Brian Tuffin, Fuse Science CEO. “This is another step in a defined plan to grow the business and create significant shareholder value.”
If you would like to understand what it means to be Powered By Fuse! today, log onto www.poweredbyfuse.com and enter Promo code “getpowered” for 20% off your EnerJel.
About Fuse Science Inc.
Fuse Science Inc. (OTCQB: DROP), is an innovative consumer products holding company based in Miami Lakes, Florida. Fuse Science holds the rights to new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals. The company maintains the rights to sublingual and transdermal delivery systems for bioactive agents that can now, for the first time, effectively encapsulate and charge many varying molecules in order to produce complete product formulations which can bypass the gastrointestinal tract and enter the blood stream directly - all in a concentrated “DROP” form that is simply applied under the tongue. The Fuse Science technology is designed to accelerate conveyance of medicines or nutrients relative to traditional pills and liquids and can enhance how consumers receive these products. Information about Fuse Science is available online at www.fusescience.com and www.poweredbyfuse.com or by calling 305-503-FUSE (3873).
Safe Harbor Statement: Certain statements and information included in this release may constitute “forward-looking statements” as defined in the Federal Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied in such statements. Additional discussion of factors that could cause actual results to differ materially from management’s projections, estimates and expectations is contained in the Company’s SEC filings. The Company assumes no obligation to update any forward-looking statements as a result of new information, future events or developments, except as required by federal securities laws.
SOURCE Fuse Science Inc.